{"id":"W3170024542","doi":"10.1200/jco.2021.39.15_suppl.8503","title":"Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Internal medicine; Clinical endpoint; Lung cancer; Oncology; Chemotherapy; Neoadjuvant therapy; Adverse effect; Randomized controlled trial; Surgery; Cancer; Immunotherapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001047845,0.0004294513,0.002968791,0.00005355948,0.0001430168,0.00004930863,0.0002492106,0.0004259943,0.0009607522],"category_scores_gemma":[0.000443674,0.0002196525,0.001072481,0.0001785545,0.0001441083,0.0001093447,0.00005830775,0.0006114607,0.00001127112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001289831,"about_ca_system_score_gemma":0.004312733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007417779,"about_ca_topic_score_gemma":0.0004538529,"domain_scores_codex":[0.9957412,0.0002870364,0.002282432,0.0005594956,0.0005891125,0.000540751],"domain_scores_gemma":[0.9917996,0.004379286,0.001903043,0.0005464217,0.0008645473,0.0005071065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3599859,0.03446708,0.5010943,0.00008010044,0.005545188,0.001512213,0.0005513872,0.00002469512,0.00005867642,0.00000935937,0.01801268,0.0786584],"study_design_scores_gemma":[0.7316564,0.05015557,0.08337531,0.0005201628,0.003211132,0.00005952425,0.0001206374,0.0001386511,0.004520527,0.00004270375,0.1258891,0.0003102952],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9722673,0.00207156,0.00003505795,0.02082552,0.001523408,0.002013813,0.0001188229,0.000016609,0.001127924],"genre_scores_gemma":[0.9801387,0.006662161,0.002949177,0.004618961,0.002590048,0.0003478928,0.0001289376,0.00009917331,0.002464972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.417719,"threshold_uncertainty_score":0.9999525,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07011551329818771,"score_gpt":0.4443878089146798,"score_spread":0.3742722956164921,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}